- Home
- APLM vs MHUA Comparison
APLM vs MHUA Comparison
Compare APLM & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- MHUA
- Stock Information
- Founded
- APLM 2016
- MHUA 1990
- Country
- APLM United States
- MHUA China
- Employees
- APLM N/A
- MHUA N/A
- Industry
- APLM Blank Checks
- MHUA Medical Specialities
- Sector
- APLM Finance
- MHUA Health Care
- Exchange
- APLM Nasdaq
- MHUA Nasdaq
- Market Cap
- APLM 15.6M
- MHUA 15.6M
- IPO Year
- APLM N/A
- MHUA 2022
- Fundamental
- Price
- APLM $7.89
- MHUA $0.43
- Analyst Decision
- APLM Strong Buy
- MHUA
- Analyst Count
- APLM 2
- MHUA 0
- Target Price
- APLM $425.00
- MHUA N/A
- AVG Volume (30 Days)
- APLM 106.0K
- MHUA 1.4M
- Earning Date
- APLM 08-14-2024
- MHUA 12-27-2024
- Dividend Yield
- APLM N/A
- MHUA N/A
- EPS Growth
- APLM N/A
- MHUA 29.93
- EPS
- APLM N/A
- MHUA 0.37
- Revenue
- APLM $2,101,000.00
- MHUA $94,252,537.00
- Revenue This Year
- APLM N/A
- MHUA N/A
- Revenue Next Year
- APLM N/A
- MHUA N/A
- P/E Ratio
- APLM N/A
- MHUA $1.34
- Revenue Growth
- APLM 70.54
- MHUA N/A
- 52 Week Low
- APLM $6.50
- MHUA $0.25
- 52 Week High
- APLM $105.00
- MHUA $2.81
- Technical
- Relative Strength Index (RSI)
- APLM 42.42
- MHUA 49.60
- Support Level
- APLM $7.70
- MHUA $0.47
- Resistance Level
- APLM $8.88
- MHUA $0.67
- Average True Range (ATR)
- APLM 1.34
- MHUA 0.06
- MACD
- APLM -0.04
- MHUA 0.01
- Stochastic Oscillator
- APLM 24.77
- MHUA 46.64
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.